Morten Hindsø1, Kirstine Nyvold Bojsen-Møller2, Gerrit van Hall3,4, Sten Madsbad2, Viggo Bjerregaard Kristiansen5, Jens Juul Holst3,6. 1. Department of Endocrinology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark. morten.hindsoe@regionh.dk. 2. Department of Endocrinology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark. 3. Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark. 4. Clinical Metabolomics Core Facility, Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark. 5. Department of Surgical Gastroenterology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark. 6. Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
Abstract
INTRODUCTION: Roux-en-Y gastric bypass (RYGB) surgery markedly increases the rate of intestinal nutrient exposure after food intake, accelerates intestinal absorption of dietary glucose and protein, and alters the postprandial gut hormone response. However, our understanding of postprandial fat absorption and metabolism after RYGB is incomplete. METHODS: Stable palmitate tracers were administered intravenously (K-[2,2-2H2]palmitate) and orally with a mixed meal ([U-13C16]palmitate) to study fatty acid absorption and metabolism before and 3 months after RYGB in 10 participants with obesity and normal glucose tolerance. RESULTS: There was a tendency toward reduced fasting plasma nonesterified palmitate concentrations after RYGB, but neither fasting palmitate kinetics nor fasting triacylglycerol (TAG) concentrations changed compared with before surgery. Postprandial TAG concentrations were numerically, but nonsignificantly, reduced 3-4 h after meal intake after compared with before RYGB. However, the postprandial appearance of the oral palmitate tracer in the plasma TAG pool and overflow into the nonesterified palmitate pool were initially faster but overall reduced after RYGB by 50% (median, IQR: [47;64], P = 0.004) and 46% (median, IQR: [33;70], P = 0.041), respectively. The maximal postprandial suppression of plasma nonesterified palmitate concentrations was slightly greater but shorter lasting after RYGB ('time × visit' interaction: P < 0.001), without detectable effects of surgery on the rate of appearance and disappearance of plasma palmitate. CONCLUSION: RYGB resulted in an initially accelerated but overall ~50% reduced 4-h postprandial systemic appearance of dietary palmitate in participants with obesity and normal glucose tolerance. This is likely a result of faster but incomplete intestinal fat absorption combined with enhanced chylomicron-TAG clearance, but it needs further investigation in studies specifically designed to investigate these mechanisms.
INTRODUCTION: Roux-en-Y gastric bypass (RYGB) surgery markedly increases the rate of intestinal nutrient exposure after food intake, accelerates intestinal absorption of dietary glucose and protein, and alters the postprandial gut hormone response. However, our understanding of postprandial fat absorption and metabolism after RYGB is incomplete. METHODS: Stable palmitate tracers were administered intravenously (K-[2,2-2H2]palmitate) and orally with a mixed meal ([U-13C16]palmitate) to study fatty acid absorption and metabolism before and 3 months after RYGB in 10 participants with obesity and normal glucose tolerance. RESULTS: There was a tendency toward reduced fasting plasma nonesterified palmitate concentrations after RYGB, but neither fasting palmitate kinetics nor fasting triacylglycerol (TAG) concentrations changed compared with before surgery. Postprandial TAG concentrations were numerically, but nonsignificantly, reduced 3-4 h after meal intake after compared with before RYGB. However, the postprandial appearance of the oral palmitate tracer in the plasma TAG pool and overflow into the nonesterified palmitate pool were initially faster but overall reduced after RYGB by 50% (median, IQR: [47;64], P = 0.004) and 46% (median, IQR: [33;70], P = 0.041), respectively. The maximal postprandial suppression of plasma nonesterified palmitate concentrations was slightly greater but shorter lasting after RYGB ('time × visit' interaction: P < 0.001), without detectable effects of surgery on the rate of appearance and disappearance of plasma palmitate. CONCLUSION: RYGB resulted in an initially accelerated but overall ~50% reduced 4-h postprandial systemic appearance of dietary palmitate in participants with obesity and normal glucose tolerance. This is likely a result of faster but incomplete intestinal fat absorption combined with enhanced chylomicron-TAG clearance, but it needs further investigation in studies specifically designed to investigate these mechanisms.
Authors: Harold Bays; Shanu N Kothari; Dan E Azagury; John M Morton; Ninh T Nguyen; Peter H Jones; Terry A Jacobson; David E Cohen; Carl Orringer; Eric C Westman; Deborah B Horn; Wendy Scinta; Craig Primack Journal: Surg Obes Relat Dis Date: 2016-01-12 Impact factor: 4.734
Authors: Lars Sjöström; Markku Peltonen; Peter Jacobson; C David Sjöström; Kristjan Karason; Hans Wedel; Sofie Ahlin; Åsa Anveden; Calle Bengtsson; Gerd Bergmark; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Jan Karlsson; Anna-Karin Lindroos; Hans Lönroth; Kristina Narbro; Ingmar Näslund; Torsten Olbers; Per-Arne Svensson; Lena M S Carlsson Journal: JAMA Date: 2012-01-04 Impact factor: 56.272
Authors: Sean P Heffron; Amar Parikh; Alexandar Volodarskiy; Christine Ren-Fielding; Arthur Schwartzbard; Joseph Nicholson; Sripal Bangalore Journal: Am J Med Date: 2016-02-18 Impact factor: 4.965
Authors: Kirstine N Bojsen-Møller; Siv H Jacobsen; Carsten Dirksen; Nils B Jørgensen; Søren Reitelseder; Jens-Erik B Jensen; Viggo B Kristiansen; Jens J Holst; Gerrit van Hall; Sten Madsbad Journal: Am J Clin Nutr Date: 2015-08-05 Impact factor: 7.045
Authors: Chun Shing Kwok; Ashish Pradhan; Muhammad A Khan; Simon G Anderson; Bernard D Keavney; Phyo Kyaw Myint; Mamas A Mamas; Yoon K Loke Journal: Int J Cardiol Date: 2014-02-24 Impact factor: 4.164